Johnathan Alexander McLean

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
RET kinase inhibitors
- Patent number 11,970,485
- Issue date Apr 30, 2024
- Eli Lilly and Company
- Gabrielle R. Kolakowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K...
- Patent number 11,878,970
- Issue date Jan 23, 2024
- Petra Pharma Corporation
- Erin Danielle Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RET kinase inhibitors
- Patent number 11,697,647
- Issue date Jul 11, 2023
- Eli Lilly and Company
- Gabrielle R. Kolakowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K...
- Patent number 11,649,227
- Issue date May 16, 2023
- Petra Pharma Corporation
- Erin Danielle Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ERK inhibitors
- Patent number RE48635
- Issue date Jul 13, 2021
- Eli Lilly and Company
- Guillermo S. Cortez
Information Patent Grant
ERK inhibitors
- Patent number 9,879,029
- Issue date Jan 30, 2018
- Eli Lilly and Company
- Guillermo S. Cortez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ERK inhibitors
- Patent number 9,469,652
- Issue date Oct 18, 2016
- Eli Lilly and Company
- Guillermo S. Cortez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives as kinase inhibitors
- Patent number 8,058,425
- Issue date Nov 15, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
- Patent number 7,666,879
- Issue date Feb 23, 2010
- Eli Lilly and Company
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...
- Publication number 20230286960
- Publication date Sep 14, 2023
- Petra Pharma Corporation
- Erin Danielle ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RET KINASE INHIBITORS
- Publication number 20230265085
- Publication date Aug 24, 2023
- Eli Lilly and Company
- Gabrielle R. KOLAKOWSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...
- Publication number 20230096175
- Publication date Mar 30, 2023
- Petra Pharma Corporation
- Erin Danielle ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...
- Publication number 20220372023
- Publication date Nov 24, 2022
- Petra Pharma Corporation
- Erin Danielle ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RET KINASE INHIBITORS
- Publication number 20220144816
- Publication date May 12, 2022
- Eli Lilly and Company
- Gabrielle R. Kolakowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK INHIBITORS
- Publication number 20170267691
- Publication date Sep 21, 2017
- Eli Lilly and Company
- Guillermo S. Cortez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ERK INHIBITORS
- Publication number 20160176896
- Publication date Jun 23, 2016
- Eli Lilly and Company
- Guillermo S. Cortez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110294792
- Publication date Dec 1, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110207721
- Publication date Aug 25, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS
- Publication number 20090227622
- Publication date Sep 10, 2009
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20090105229
- Publication date Apr 23, 2009
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purine derivatives as kinase inhibitors
- Publication number 20050090483
- Publication date Apr 28, 2005
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY

Johnathan Alexander McLean

Person

Patents Grantslast 30 patents

RET kinase inhibitors

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K...

RET kinase inhibitors

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K...

ERK inhibitors

ERK inhibitors

ERK inhibitors

Purine derivatives as kinase inhibitors

Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors

Patents Applicationslast 30 patents

ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...

RET KINASE INHIBITORS

ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...

ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K...

RET KINASE INHIBITORS

ERK INHIBITORS

ERK INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

Purine derivatives as kinase inhibitors